Abstract
In the ALLHAT randomized trial, hypertensive patients (age ≥55) with at least one other coronary heart disease (CHD) risk factor had similar rates of the primary endpoint (fatal CHD or nonfatal MI) with the diuretic chlorthalidone, the calcium-channel blocker (CCB) amlodipine, and the ACE inhibitor lisinopril (Journal Watch Cardiology Jan 31 2003). Now, researchers have conducted an …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
